CIVENTICHEM CV-4057
|
|
|
- CAS-Nr.
- 248281-84-7
- Englisch Name:
- CIVENTICHEM CV-4057
- Synonyma:
- LAQ;CS-82;ABR 215062;ABR-215062;Lanquinimod;oro-N-ethyL;CIVENTICHEM;-2-oxo-N-phenyL;Laquinimod, >=98%;ine-3-carboxamide
- CBNumber:
- CB7836628
- Summenformel:
- C19H17ClN2O3
- Molgewicht:
- 356.8
- MOL-Datei:
- 248281-84-7.mol
|
CIVENTICHEM CV-4057 Eigenschaften
- Schmelzpunkt:
- 201 °C (decomp)
- Siedepunkt:
- 484.8±45.0 °C(Predicted)
- Dichte
- 1.395±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- Löslichkeit
- Soluble in DMSO (>25 mg/ml)
- Aggregatzustand
- solid
- pka
- 4.50±1.00(Predicted)
- Farbe
- Off-white
- Stabilität:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| Kennzeichnung gefährlicher |
T |
|
|
| R-Sätze: |
25 |
|
|
| S-Sätze: |
45 |
|
|
| RIDADR |
UN 2811 6.1 / PGIII |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Achtung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H301 |
Giftig bei Verschlucken. |
Akute Toxizität oral |
Kategorie 3 |
Achtung |
![GHS hazard pictograms]() src="/GHS06.jpg" width="20" height="20" /> |
P264, P270, P301+P310, P321, P330,P405, P501 |
|
| Sicherheit |
| P301+P310 |
BEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen. |
|
CIVENTICHEM CV-4057 Chemische Eigenschaften,Einsatz,Produktion Methoden
CIVENTICHEM CV-4057 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
CIVENTICHEM CV-4057 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 127)Lieferanten
248281-84-7()Verwandte Suche:
- LAQ
- Laquinimod potassium salt
- 5-Chloro-N-Et-4-hydroxy-1-methyl-2-oxo-N-Ph-1,2-dihydroquinoline-3-carboxamide
- Laquinimod, >=98%
- CIVENTICHEM CV-4057
- LAQUINIMOD,5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID ETHYL-PHENYL-AMIDE
- 5-Chloro-4-hydroxy-1-Methyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid ethyl-phenyl-aMide
- LaquiniMod, SAIK-MS coMpound, ABR-215062
- 5-Chloro-4-hydroxy-1-methyl-2-oxo-N-ethyl-N-phenyl-1,2-dihydroquinoline-3-carboxamide
- Lanquinimod
- LaquiniMod,CiventicheMCV-4057,5-Chloro-4-hydroxy-1-Methyl-2-oxo-1,2-dihydroquinoline-3-carboxylicacidethylphenylaMide
- 5-chloro-N-ethyl-4-hydroxy-1-Methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxaMide
- ABR 215062
- ABR-215062
- LaquiniMod (ABR-215062)
- 5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenylquinoline-3-carboxamide
- -1,2-dihydroquinoL
- -2-oxo-N-phenyL
- -4-hydroxy-1-methyL
- ine-3-carboxamide
- oro-N-ethyL
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-
- 5-Chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihyd...
- ABR-215062 (Laquinimod)
- CIVENTICHEM
- CS-82
- ABR215062; ABR 215062 (LAQUINIMOD)
- inhibit,multiple sclerosis,relapsing remitting,carboxamide,Nuclear factor-kappaB,Apoptosis,Inhibitor,ABR 215062,Nuclear factor-κB,immunomodulator,ABR215062,chronic progressive,neurodegenerative disease,inflammation,NF-κB,Laquinimod,Orally,neurodegeneration
- 248281-84-7
- Inhibitors
- api
- Heterocycles
